This guidance has been developed by the NTA in consultation with experts in the field. It provides initial guidance for drug treatment practitioners on the potential role of injectable heroin and injectable methadone substitute maintenance prescribing in local drug treatment systems. The guidance is designed to complement with the current Department of Health clinical guidelines - Drug misuse and dependence: guidelines on clinical management (Department of Health, 1999).